As per LEO Pharma Inc, Adbry (tralokinumab-ldrm) is now approved for use in pediatric patients with moderate-to-severe atopic dermatitis (AD) aged 12 to 17 years. This approval extends to patients whose disease is not adequately controlled with...
Vijaya Diagnostic Centre Ltd announced that it will totally purchase Pune-based PH Diagnostic Centre Pvt Ltd for Rs 134.65 crore in cash. The board of directors of Vijaya Diagnostic Centre met on Tuesday and considered and approved the terms and...
JB Chemicals & Pharmaceuticals Ltd has signed a trade mark licence deal, as well as a promotion and distribution agreement, with Novartis for select ophthalmic brands worth Rs 1,089 crore. The board of directors approved the execution of a...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a global biotech company focused on the discovery and development of novel antibody therapeutics, has announced an antibody evaluation, option, and license agreement with Ona Therapeutics, a Spanish...
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, announced the approval of its New Drug Application (NDA) for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin...
Sun Pharmaceutical Industries Ltd announced it will pay USD 30 million (almost Rs 250 crore) for a 16.7% interest in Lyndra Therapeutics, Inc, situated in the United States. Sun Pharmaceutical Industries said in a regulatory filing that it has...
The Union Ministry of Ayush is framing guidelines under the Drugs and Cosmetics Rules, 1945 for issuance of license to the Ayurveda, Siddha, Unani and Homoeopathy drugs with the new dosage form of nasal spray in these systems, that are different...
Abbott has announced that the US has approved its innovative new automation solution, GLP Systems Track.
In a significant leap for the state's healthcare infrastructure, the Maharashtra Food and Drug Administration (FDA) has granted licenses to 23 more blood banks, taking the total to 366 blood
The World Health Organization (WHO) has published a report examining the benefits and limitations of mRNA vaccine technology, due to the potential impact of messenger ribonucleic acid (mRNA) vaccines during the COVID-19 pandemic
, CDSCO.jpg)
